- Published on: February 22, 2022
- 13:53
Havana, Feb 22 (Prensa Latina) Specialists from the Center for Genetic Engineering and Biotechnology (CIGB) are today investigating the effectiveness of Cuban drug Heberferon against several malignant tumors.